(Photo: Flickr)

Johnson & Johnson told certain hospitals in the U.S. in a notice on Friday that they will have to pay full price for two drugs – Stelara and Xarelto – that the drugmaker has been selling at a discount under the 340B drug discount program. However, the hospitals can apply at a later date for a rebate.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Core and Group Health
Health Care Reform
Employee Participation
Employee-Paid
Employer-Paid